Evaluating the Clinical Efficacy and Safety of Subcutaneous Rituximab in Non-Hodgkin Lymphoma: A Systematic Review. TMJGM [Internet]. 2024 Oct. 7 [cited 2026 Nov. 4];1(1):1-16. Available from: https://medicaljournalinternational.org/tmjgm/article/view/1